Cardiac Function Modulation in Type 2 Diabetes Through SGLT2 Inhibition
Summary
In type 2 diabetes, sodium–glucose co-transporter 2 inhibitors (SGLT2is) have evolved from purely glucose-lowering agents into therapies that confer robust cardiac protection. By blocking renal glucose reabsorption, these drugs induce natriuresis and osmotic diuresis, reducing intravascular volume and ventricular preload. Concomitantly, SGLT2is shift myocardial substrate utilisation toward ketone bodies, potentially optimising energy efficiency in the failing heart. Clinically, treatment is associated with regression of left ventricular hypertrophy, reductions in chamber volumes and improvements in both systolic and diastolic performance across heart failure phenotypes. These structural and functional benefits are paralleled by decreases in natriuretic peptides and other markers of myocardial stress. Collectively, this multifaceted mechanism translates into significant reductions in heart failure hospitalisations and cardiovascular mortality, establishing SGLT2 inhibition as a disease-modifying approach in people with type 2 diabetes.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Cardiac Function Modulation in Type 2 Diabetes Through SGLT2 Inhibition publication trend
The graph below shows the total number of articles in cardiac function modulation in type 2 diabetes through sglt2 inhibition across all publications each year (not limited to Nature Index journals).
Technical terms
Sodium–glucose co-transporter 2 (SGLT2): A protein in the renal proximal tubule responsible for reclaiming filtered glucose; its inhibition promotes urinary glucose and sodium excretion.
Left ventricular ejection fraction (LVEF): The percentage of blood volume ejected from the left ventricle during systole, used as a measure of systolic performance.
Diastolic function: The capacity of the left ventricle to relax and fill during diastole, often assessed by echocardiographic parameters such as the mitral inflow E/e′ ratio.
Myocardial energetics: The processes by which cardiac cells generate adenosine triphosphate (ATP), frequently quantified by the phosphocreatine:ATP ratio via magnetic resonance spectroscopy.
Left ventricular remodelling: Structural adaptations of the ventricular myocardium—changes in mass, geometry and volume—that occur in response to chronic stress and may be reversed by therapeutic interventions.
References
- Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial. Circulation (2023).
- A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial. European Heart Journal (2020).
- Effect of sodium–glucose cotransporter 2 inhibitors on cardiac structure and function in type 2 diabetes mellitus patients with or without chronic heart failure: a meta-analysis. Cardiovascular Diabetology (2021).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.